Valganciclovir Powder, For Solution
Product Images NDC 42571-477

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 42571-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-cartn.jpg (Valganciclovir Cartn)

Packaging label for Valganciclovir for Oral Solution, USP 50 mg/mL, a powder for oral solution supplied in a 100 mL (3.4 fl oz) bottle. The label includes preparation instructions, dosage information, storage conditions, and manufacturer details. Labeler is Micro Labs Limited, and the NDC is 42571-477-47.*

FDA Label Image

Valganciclovir-equ.jpg (Valganciclovir Equ)

Mathematical formulas for Mosteller Body Surface Area (BSA) and Schwartz Creatinine Clearance calculation. The Mosteller BSA formula uses height in centimeters and weight in kilograms. The Schwartz Creatinine Clearance formula uses a constant k, height in centimeters, and serum creatinine in mg/dL.*

FDA Label Image

Valganciclovir-lbel.jpg (Valganciclovir Lbel)

Label for Valganciclovir for Oral Solution USP, 50 mg/mL powder for solution in a 100 mL (3.4 fl oz) bottle. The label includes preparation instructions, dosage information, storage conditions, and discard guidelines. It is manufactured by Micro Labs Limited and Micro Labs USA, Inc.*

FDA Label Image

Valganciclovir-s0.jpg (Valganciclovir S0)

An instructional diagram illustrating an oral dispenser assembly for medication. It labels parts including the child resistant cap, bottle adapter, bottle, and the oral dispenser components: plunger, barrel with volume markings, and tip. The diagram visually explains how these parts fit together for dosing.*

FDA Label Image

Valganciclovir-s1.jpg (Valganciclovir S1)

An illustration showing a hand holding a bottle with instructions to "Shake well." This likely demonstrates the proper preparation of an oral powder for solution medication.*

FDA Label Image

Valganciclovir-s10.jpg (Valganciclovir S10)

An instructional illustration showing a faucet dripping water into a syringe held horizontally. This image likely demonstrates the process of rinsing, cleaning, or preparing a syringe for use.*

FDA Label Image

Valganciclovir-s2.jpg (Valganciclovir S2)

An instructional diagram showing how to open a vial by twisting the cap. The image depicts a vial neck with an arrow indicating downward pressure and a curved arrow indicating rotational movement to remove or open the vial cap.*

FDA Label Image

Valganciclovir-s3.jpg (Valganciclovir S3)

An instructional illustration showing an oral dosage indicator syringe, used for measuring liquid medication doses in milliliters (mL). The syringe features measurement markings along its barrel and a plunger to adjust the dose volume.*

FDA Label Image

Valganciclovir-s4.jpg (Valganciclovir S4)

An instructional line drawing depicting a hand holding a syringe with a plunger being depressed. The illustration appears to demonstrate the technique for pressing the syringe plunger downwards, likely related to preparing or administering an oral solution.*

FDA Label Image

Valganciclovir-s5.jpg (Valganciclovir S5)

An instructional black-and-white line drawing depicting a hand holding a measuring syringe above a bottle with an open adapter. The image illustrates how to use the bottle adapter opening for withdrawing medication into the syringe, likely for the oral powder solution of valganciclovir.*

FDA Label Image

Valganciclovir-s6.jpg (Valganciclovir S6)

An instructional illustration showing a person holding a bottle and using a syringe to draw liquid medication from it. The syringe is marked with volume measurements up to 12 mL, indicating how to measure the dosage accurately. The bottle is upside down above the syringe, depicting the typical method of extracting oral solution medication.*

FDA Label Image

Valganciclovir-s7.jpg (Valganciclovir S7)

An instructional illustration showing a hand holding and inserting a syringe or measuring device into the neck of a bottle. The bottle is open and appears intended for withdrawing liquid, likely related to preparation or dosing of the powdered oral solution of VALGANCICLOVIR.*

FDA Label Image

Valganciclovir-s8.jpg (Valganciclovir S8)

An instructional diagram depicting the administration of an oral solution using a syringe. The illustration shows a person with their mouth open, receiving the medication from a syringe held by another hand, indicating correct oral delivery technique.*

FDA Label Image

Valganciclovir-s9.jpg (Valganciclovir S9)

VALGANCICLOVIR 50 mg/mL powder for solution in an oral dosage form presented in a small vial with a safety cap, labeled by Micro Labs Limited. The image shows the bottle's upper portion, including the cap and neck, without detailed text or graphics.*

FDA Label Image

Valganciclovir-stru.jpg (Valganciclovir Stru)

Chemical structure of valganciclovir hydrochloride as shown in the image, illustrating the molecular arrangement of the active ingredient valganciclovir with its hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.